jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
cleye 0.12 mg/ ml
elara pharmaservices europe ltd - nafazolinhydroklorid - Øyedråper, oppløsning - 0.12 mg/ ml
kloramfenikol santen 10 mg/ g
santen oy - kloramfenikol - Øyesalve - 10 mg/ g
simplex 200 mg/ g / 800 mg/ g
teva b.v. - parafin, flytende / vaselin, gul - Øyesalve - 200 mg/ g / 800 mg/ g
cosopt sine 20 mg/ ml / 5 mg/ ml
santen oy - dorzolamidhydroklorid / timololmaleat - Øyedråper, oppløsning - 20 mg/ ml / 5 mg/ ml
taflotan sine 15 mikrog/ ml
santen oy - tafluprost - Øyedråper, oppløsning - 15 mikrog/ ml